BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27823565)

  • 1. An Improved Comparative Docking Approach for Developing Specific Glycogen Phosphorylase Inhibitors Using Pentacyclic Triterpenes.
    Konkimalla VB
    Curr Top Med Chem; 2017; 17(14):1640-1645. PubMed ID: 27823565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors.
    Luo JG; Liu J; Kong LY
    Chem Biodivers; 2008 May; 5(5):751-7. PubMed ID: 18493961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of ambradiolic acid as an inhibitor of glycogen phosphorylase.
    Liu J; Zhang H; Zhu P; Wu X; Yao H; Ye W; Jiang J; Xu J
    Fitoterapia; 2015 Jan; 100():50-5. PubMed ID: 25447165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase.
    Zhang P; Hao J; Liu J; Lu Q; Sheng H; Zhang L; Sun H
    J Nat Prod; 2009 Aug; 72(8):1414-8. PubMed ID: 19642687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, screening and docking of small heterocycles as glycogen phosphorylase inhibitors.
    Schweiker SS; Loughlin WA; Lohning AS; Petersson MJ; Jenkins ID
    Eur J Med Chem; 2014 Sep; 84():584-94. PubMed ID: 25062009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
    Liang Z; Zhang L; Li L; Liu J; Li H; Zhang L; Chen L; Cheng K; Zheng M; Wen X; Zhang P; Hao J; Gong Y; Zhang X; Zhu X; Chen J; Liu H; Jiang H; Luo C; Sun H
    Eur J Med Chem; 2011 Jun; 46(6):2011-21. PubMed ID: 21439694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.
    Wen X; Sun H; Liu J; Wu G; Zhang L; Wu X; Ni P
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4944-8. PubMed ID: 16169219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes.
    Leonidas DD; Hayes JM; Kato A; Skamnaki VT; Chatzileontiadou DS; Kantsadi AL; Kyriakis E; Chetter BA; Stravodimos GA
    Curr Med Chem; 2017; 24(4):384-403. PubMed ID: 27855623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
    J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentacyclic triterpenoids from spikes of Prunella vulgaris L. inhibit glycogen phosphorylase and improve insulin sensitivity in 3T3-L1 adipocytes.
    Yu Q; Qi J; Wang L; Liu SJ; Yu BY
    Phytother Res; 2015 Jan; 29(1):73-9. PubMed ID: 25278372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
    Chen J; Liu J; Zhang L; Wu G; Hua W; Wu X; Sun H
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2915-9. PubMed ID: 16546381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies.
    Taha MO; Habash M; Al-Hadidi Z; Al-Bakri A; Younis K; Sisan S
    J Chem Inf Model; 2011 Mar; 51(3):647-69. PubMed ID: 21370899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
    Wang Y; Yan Z; Guo Y; Zhang L
    Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
    Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
    Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
    Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
    Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
    Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
    Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel pentacyclic triterpene derivatives as potential PPARγ agonists.
    Zhang L; Dong J; Liu J; Zhang L; Kong L; Yao H; Sun H
    Med Chem; 2013 Feb; 9(1):118-25. PubMed ID: 22779802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.